Routes of
administration Oral IUPHAR/BPS 7683 Formula C13H21N3O Molar mass 235.33 g/mol | PubChem CID 10263487 ChemSpider 8438966 3D model (Jmol) Interactive image | |
 | ||
PF-592,379 is a drug developed by Pfizer which acts as a potent, selective and orally active agonist for the dopamine D3 receptor, which is under development as a potential medication for the treatment of female sexual dysfunction and male erectile dysfunction. Unlike some other less selective D3 agonists, PF-592,379 showed no evidence of abuse potential in animal studies, and so was selected for further development and potentially human clinical trials.
References
PF-592,379 Wikipedia(Text) CC BY-SA